Product Code: ETC5359016 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Ireland Buprenorphine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Beginning strongly at 0.01% in 2025, growth softens to 0.00% in 2029.
By 2027, the Buprenorphine market in Ireland is anticipated to reach a growth rate of 0.00%, as part of an increasingly competitive Europe region, where Germany remains at the forefront, supported by United Kingdom, France, Italy and Russia, driving innovations and market adoption across sectors.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Buprenorphine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Buprenorphine Market - Industry Life Cycle |
3.4 Ireland Buprenorphine Market - Porter's Five Forces |
3.5 Ireland Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Ireland Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Ireland Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the benefits of buprenorphine treatment |
4.2.2 Growing government initiatives to combat opioid abuse and support addiction treatment programs |
4.2.3 Rising healthcare expenditure and accessibility to buprenorphine treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations and monitoring requirements for buprenorphine prescription and dispensing |
4.3.2 Limited availability of healthcare professionals trained in prescribing buprenorphine |
4.3.3 Stigma and misconceptions surrounding opioid addiction and medication-assisted treatment |
5 Ireland Buprenorphine Market Trends |
6 Ireland Buprenorphine Market Segmentations |
6.1 Ireland Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Ireland Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Ireland Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Ireland Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Ireland Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Ireland Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Ireland Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Ireland Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Ireland Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Ireland Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Ireland Buprenorphine Market Import-Export Trade Statistics |
7.1 Ireland Buprenorphine Market Export to Major Countries |
7.2 Ireland Buprenorphine Market Imports from Major Countries |
8 Ireland Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment |
8.2 Percentage increase in patients opting for buprenorphine therapy |
8.3 Rate of successful treatment outcomes with buprenorphine therapy |
9 Ireland Buprenorphine Market - Opportunity Assessment |
9.1 Ireland Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Ireland Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Ireland Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Buprenorphine Market - Competitive Landscape |
10.1 Ireland Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |